Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-26 Sale | 2023-12-27 6:30 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 4,272 | $9.24 | $39,473 | 111,550 (Direct) | View |
| 2023-06-28 Sale | 2023-06-29 4:59 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 759 | $11.4 | $8,653 | 115,822 (Direct) | View |
| 2023-05-23 Sale | 2023-05-24 4:36 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 707 | $9.15 | $6,469 | 116,581 (Direct) | View |
| 2023-04-25 Sale | 2023-04-26 4:23 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 716 | $10.59 | $7,582 | 117,288 (Direct) | View |
| 2023-03-23 Sale | 2023-03-27 4:05 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 706 | $10.51 | $7,420 | 118,004 (Direct) | View |
| 2022-06-06 Purchase | 2022-06-07 4:33 pm | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 8,090 | $12.4 | $100,316 | 8,090 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-23 5:00 pm | N/A 2034-02-22 | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 480,000 | $0 | 591,550 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-23 5:06 pm | N/A 2033-02-21 | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 320,000 | $0 | 329,710 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 6:04 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 1,620 | $10.9 | 9,710 (Direct) | View |
| 2022-03-05 Option Award | 2022-03-07 9:50 pm | N/A 2025-03-05 | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 215,000 | $0 | 215,000 (Direct) | View |
| 2021-10-18 Option Award | 2021-10-20 4:35 pm | N/A 2031-10-17 | Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO | 2,710,000 | $0 | 2,710,000 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 8:13 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 7,660 | $62.03 | 40,855 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 8:13 pm | N/A 2020-12-31 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 14,946 | $0 | 40,855 (Direct) | View |
| 2020-12-02 Tax Withholding | 2020-12-03 8:24 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 3,380 | $62.18 | 53,351 (Direct) | View |
| 2020-12-02 Exercise | 2020-12-03 8:24 pm | N/A 2023-12-02 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 6,594 | $0 | 53,351 (Direct) | View |
| 2020-10-30 Tax Withholding | 2020-11-03 4:28 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 2,291 | $58.45 | 30,355 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-03 4:28 pm | N/A 2020-10-30 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 4,650 | $0 | 30,355 (Direct) | View |
| 2020-05-01 Tax Withholding | 2020-05-05 4:49 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 1,433 | $60.26 | 27,996 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 4:49 pm | N/A 2020-05-01 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 2,908 | $0 | 27,996 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 6:10 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology | 53,470 | $0 | 53,470 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 8:04 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 8,473 | $59.06 | 60,931 (Direct) | View |
| 2020-03-01 Exercise | 2020-03-03 8:04 pm | N/A 2022-03-01 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 17,204 | $0 | 60,931 (Direct) | View |
| 2020-02-04 Tax Withholding | 2020-02-06 8:48 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 1,071 | $64.29 | 21,942 (Direct) | View |
| 2020-02-04 Exercise | 2020-02-06 8:48 pm | N/A 2022-02-04 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 2,076 | $0 | 21,942 (Direct) | View |
| 2019-11-20 Option Award(A) | 2020-01-03 8:37 pm | N/A 2020-12-31 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 48,129 | $0 | 48,129 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-04 4:58 pm | N/A 2023-12-02 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 26,376 | $0 | 26,376 (Direct) | View |
| 2019-11-20 Option Award | 2019-11-27 5:31 pm | N/A 2020-10-30 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 120,584 | $0 | 120,584 (Direct) | View |
| 2019-11-20 Option Award | 2019-11-27 5:31 pm | N/A 2022-01-30 | BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM President, Hematology | 306,324 | $0 | 306,324 (Direct) | View |
| 2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2027-01-30 | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 94,975 | $0 | 0 (Direct) | View |
| 2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 25,875 | $0 | 0 (Direct) | View |
| 2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2022-01-30 | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 142,098 | $0 | 0 (Direct) | View |